A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma

Detalles Bibliográficos
Autores principales: Peng, Wei, Li, Si, Li, Lijian, Xiao, Mingzhe, Zhong, Jincai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474378/
https://www.ncbi.nlm.nih.gov/pubmed/34589975
http://dx.doi.org/10.1016/j.jtocrr.2020.100112
_version_ 1784575203293003776
author Peng, Wei
Li, Si
Li, Lijian
Xiao, Mingzhe
Zhong, Jincai
author_facet Peng, Wei
Li, Si
Li, Lijian
Xiao, Mingzhe
Zhong, Jincai
author_sort Peng, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-8474378
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84743782021-09-28 A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma Peng, Wei Li, Si Li, Lijian Xiao, Mingzhe Zhong, Jincai JTO Clin Res Rep Case Report Elsevier 2020-10-17 /pmc/articles/PMC8474378/ /pubmed/34589975 http://dx.doi.org/10.1016/j.jtocrr.2020.100112 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Peng, Wei
Li, Si
Li, Lijian
Xiao, Mingzhe
Zhong, Jincai
A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma
title A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma
title_full A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma
title_fullStr A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma
title_full_unstemmed A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma
title_short A Novel LINC00478/LINC01549 Intergenic Region-ALK Fusion Responded Well to Alectinib in a Patient With Lung Adenocarcinoma
title_sort novel linc00478/linc01549 intergenic region-alk fusion responded well to alectinib in a patient with lung adenocarcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474378/
https://www.ncbi.nlm.nih.gov/pubmed/34589975
http://dx.doi.org/10.1016/j.jtocrr.2020.100112
work_keys_str_mv AT pengwei anovellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT lisi anovellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT lilijian anovellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT xiaomingzhe anovellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT zhongjincai anovellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT pengwei novellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT lisi novellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT lilijian novellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT xiaomingzhe novellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma
AT zhongjincai novellinc00478linc01549intergenicregionalkfusionrespondedwelltoalectinibinapatientwithlungadenocarcinoma

Ejemplares similares